Haririan H, Andrukhov O, Bottcher M, Pablik E, Wimmer G, Moritz A, Rausch-Fan X
This is why its often given weekly
Safety and Efficacy of Bimatoprost for Eyelash Growth in Postchemotherapy Subjects
In addition, GLP-1/glucagon and GLP-1/GIP dual receptor agonists and GLP-1/GIP/glucagon triple receptor agonists have shown the potential to reduce blood glucose levels and body weight through their effects on islets and peripheral tissues, improving beta cell function and stimulating energy expenditure
Experiments indicate that different pathways like extracellular signal-regulated kinase (ERK) and WNT [20, 23] signaling pathways play a role in this
Several patterns explain why some users end up gaining weight instead of losing it